Who
Richard N. Kender
Director and Officer
Company insider
Files Form 4 as: Director and Officer, Seres Therapeutics; Director, Longeveron; Director, Bicycle Therapeutics; Director, Omega Therapeutics; Director, INC Research Holdings; Director, Foxhollow Technologies; Director, ev3.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 7
- Companies where not an officer
- 6
- First trade
- 4 Oct 2007
- Last trade
- 8 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jul 2026filed 10 Jul 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 10 May 2024filed 14 May 2024 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | $23K16,000 at $1.46 | filing |
| 4 Apr 2024filed 8 Apr 2024 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 22 Jun 2023filed 23 Jun 2023 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,500 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 5 Jul 2022filed 6 Jul 2022 | MCRB Seres TherapeuticsBiotechnology | SEC FORM 4 Code A | $200K63,492 at $3.15 | filing |
| 22 Jun 2022filed 24 Jun 2022 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 22 Jun 2022filed 24 Jun 2022 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.